Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)
Product Specifications
CAS Number
211323-03-4
SKU
C00486-1mg
Target
Integrin
Applications
Cytoskeletal Signaling
Additionnal Information
Erlizumab (anti-Integrin b2 / ITGB2 / CD18) is a humanized monoclonal antibody targeted against Integrin beta-2 and used as a therapy for hemorrhagic shock. MW: 146.66 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
